Anti-Angiopoietin-2 Antibody, clone 4L18 ZooMAb® Rabbit Monoclonal

Description

• General description: We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
• Specificity: Clone 4L18 is a ZooMAb rabbit recombinant monoclonal antibody that specifically detects Angiopoietin-2. It targets an epitope within 23 amino acids from the N-terminal region.
• Immunogen: KLH-conjugate linear peptide corresponding to 23 amino acids from the N-terminal region of human Angiopoietin-2.
• Application: Anti-Angiopoietin-2, clone 4L18 ZooMAb, Cat. No. ZRB1414, is a recombinant Rabbit monoclonal antibody that targets Angiopoietin-2 and is tested in Affinity Binding, Immunohistochemistry, Immunofluorescence, Western Blotting.
• Target description: Angiopoietin-2 (UniProt: O15123; also known as ANG-2) is encoded by the ANGPT2 gene (Gene ID: 285) in human. Angiopoietins are a family of growth factors that include Angiopoietin 1 and 2 and the orthologs 3 (in mouse) and 4 (in human). ANG-2 is a secreted glycoprotein that is expressed predominantly by endothelial cells and some smooth muscle cells in a tightly regulated manner. High expression of ANG-2 has been observed in placenta. In quiescent mature vessels its expression is shown to be low; however, upon receipt of inflammatory signals its levels are significantly elevated. ANG-2 binds to TEK/TIE2 and competes for the Angiopoietin-1 (ANG-1) binding site and modulates ANG-1 signaling. It is also reported to induce tyrosine phosphorylation of TEK/TIE2 in the absence of ANG-1. Both ANG-1 and ANG-2 have been implicated in tumor angiogenesis and ANG-2 is highly up-regulated in the vasculature of mouse and human neoplasms. It also acts as a chemoattractant and mediates the migration of a monocytes that express Tie2 receptor. ANG-2 contains a fibrinogen C-terminal domain (aa 275-495) that mediates its interaction with the TEK/TIE2 receptor. Three isoforms of ANG-2 have been described that are produced by alternative splicing. This ZooMAb® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Scholz, A., et al. (2015). Ann. N.Y. Acad. Sci. 1347; 45-51; Felcht, M., et al. (2012). J. Clin. Invest. 122(6); 1991-2005).
• Physical form: Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.
• Reconstitution: 0.3 mg/mL after reconstitution at 25μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
• Storage and Stability: Recommended storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
• Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
• Disclaimer: Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.